Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1985 Nov;22(5):819–821. doi: 10.1128/jcm.22.5.819-821.1985

Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli: correlation between MICs of clinical isolates and quality control organisms.

T A Larson, L R Peterson, D N Gerding
PMCID: PMC268534  PMID: 3932459

Abstract

The monthly variation in geometric mean MICs (GMICs) of amikacin, tobramycin, and gentamicin for Escherichia coli and Pseudomonas aeruginosa laboratory controls and clinical isolates was followed for 30 months. For 19 months, MICs were determined by using Micro-Media system (MMS; Micro-Media Systems, Inc., Potomac, Md.) microdilution panels, and for the other 11 months, MicroScan (MS; American Scientific Products, McGaw Park, Ill.) MIC test panels were used. The aminoglycoside GMICs for control E. coli and P. aeruginosa were significantly lower with the MS system than with the MMS system. A significant correlation was observed between the GMICs for controls and clinical isolates more frequently with the MMS system than with the MS system. Differences are believed to be related to the criteria used in the selection of quality control strains.

Full text

PDF
819

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Jones R. N., Gavan T. L. Evaluation of the micro-media system for quantitative antimicrobial drug susceptibility testing: a collaborative study. Antimicrob Agents Chemother. 1978 Jan;13(1):61–69. doi: 10.1128/aac.13.1.61. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cherne J. E., Peterson L. R. Microdilution aminoglycoside susceptibility testing of Pseudomonas aeruginosa and Escherichia coli with a cation-supplemented inoculum. Antimicrob Agents Chemother. 1980 Jul;18(1):210–211. doi: 10.1128/aac.18.1.210. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Garrod L. P., Waterworth P. M. Effect of medium composition on the apparent sensitivity of Pseudomonas aeruginosa to gentamicin. J Clin Pathol. 1969 Sep;22(5):534–538. doi: 10.1136/jcp.22.5.534. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Gavan T. L., Jones R. N., Barry A. L. Evaluation of the Sensititre system for quantitative antimicrobial drug susceptibility testing: a collaborative study. Antimicrob Agents Chemother. 1980 Mar;17(3):464–469. doi: 10.1128/aac.17.3.464. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Pollock H. M., Minshew B. H., Kenny M. A., Schoenknecht F. D. Effect of different lots of Mueller-Hinton agar on the interpretation of the gentamicin susceptibility of Pseudomonas aeruginosa. Antimicrob Agents Chemother. 1978 Sep;14(3):360–367. doi: 10.1128/aac.14.3.360. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Woolfrey B. F., Fox J. M., Lally R. T., Quall C. O. Broth microdilution testing of Pseudomonas aeruginosa and aminoglycosides: need for employing dilutions differing by small arithmetic increments. J Clin Microbiol. 1982 Oct;16(4):663–667. doi: 10.1128/jcm.16.4.663-667.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Woolfrey B. F., Lally R. T., Quall C. O. Comparative evaluation of the micro-media system, sceptor, and MIC-2000 microdilution methods for testing Pseudomonas aeruginosa against gentamicin, tobramycin, and amikacin. J Clin Microbiol. 1983 Feb;17(2):312–316. doi: 10.1128/jcm.17.2.312-316.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES